CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark - InnoCan Pharma (OTC:INNPF)

Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.

Related Keywords

Chicago ,Illinois ,United States ,Iris Bincovich ,Roni Kamhi ,Innocan Pharma Corp ,Bi Sky Global Ltd ,Benzinga Cannabis Capital Conference ,